क्यूआर कोड

Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis

Abstract Background Osteosarcoma is the most prevalent primary malignant bone tumor affecting pediatric and adolescent individuals. However, despite the passage of three decades, there has been no notable enhancement in the overall survival rate of patients with osteosarcoma. In recent years, CD155...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Junkai Chen, Hongbo Li, Qinglin Jin, Xiaoguang Li, Yiwen Zhang, Jingnan Shen, Gang Huang, Junqiang Yin, Changye Zou, Xinyu Li, Xin He, Xianbiao Xie, Tiao Lin
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMC 2025-04-01
श्रृंखला:Cellular & Molecular Biology Letters
विषय:
CD155
Osteosarcoma
β-catenin
Stemness
Troxerutin
ऑनलाइन पहुंच:https://doi.org/10.1186/s11658-025-00724-8
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन